Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

Novartis raises pressure in Pfizer’s Ibrance with new Kisqali data

Women on Kisqali were found to have a longer PFS than those on hormonal therapy alone

Bristol-Myers Squibb (BMS) building

BMS adds another EU indication to Opdivo’s growing list

Wins European licence to treat high-risk advanced melanoma

- PMLiVE

GSK to replace R&D head Vallance with Calico’s Hal Barron

Barron will also hold an executive director position on GSK’s board

- PMLiVE

Novartis strengthens autoimmune indications for Cosentyx

Data shows its IL-17A inhibitor can reduce structural disease progression

- PMLiVE

MorphoSys appoints Dr Markus Enzelberger as CSO

He succeeds Dr Marlies Sproll who resigns

- PMLiVE

Revolutionising how healthcare is delivered

The big technology shift sweeping the global connection of healthcare

- PMLiVE

Porterhouse Medical appoints new talent manager

Jan Coetzee joins the team

Bristol-Myers Squibb (BMS) building

BMS’ Opdivo/Yervoy combination demonstrates OS benefit

Better kidney cancer symptom control reported versus sunitinib was also reported

- PMLiVE

Warning signs

Making the most of multichannel marketing

- PMLiVE

Reig Jofre bolsters its senior team

Gabriel Roig and Roser Gomila join as COO and CFO, respectively

- PMLiVE

Boehringer builds evidence base for its Humira biosimilar

Cyltezo shows clinical equivalence to AbbVie's blockbuster in a late-stage trial

Nobody knew healthcare was so complicated

short term and long term solutions

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links